Skip to content
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
Archyde

Archyde

  • News
  • World
  • Economy
  • Technology
  • Health
  • Entertainment
  • Sport

personalized mRNA cancer vaccine

Inside Moderna and Merck's Cancer Vaccine Breakthrough

Inside Moderna and Merck’s Cancer Vaccine Breakthrough

August 28, 2026 by Dr. Priya Deshmukh - Senior Editor, Health

In a milestone for medical research, Moderna and Merck & Co. announced that their personalized mRNA cancer vaccine achieved success in a late-stage clinical trial.

Categories Health Tags cutaneous melanoma treatment, INTerpath-001 clinical trial, intismeran autogene, Merck & Co., Moderna, Pembrolizumab, personalized mRNA cancer vaccine Leave a comment

Recent Posts

  • Private vs. Federal Student Loans: How to Get $0 Monthly Payments
  • Memorable Weekend Highlights in Guangzhou
  • Crime Roundup: Instagram Date Shootout, FLDS Sentencing, and More
  • 3 Best New Netflix Movies to Watch This Weekend
  • Gymnast Profiles & High Scores Directory
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
© 2026 Archyde — All Rights Reserved. Contact | Privacy Policy